LOXL1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis, and functions as tumor promoter to regulate osteosarcoma cell proliferation, migration, and invasion through PI3K-AKT pathway. The gene discussed is LOXL1; the disease is neoplasm.